RhumbLine Advisers
ASND icon

RhumbLine Advisers’s Ascendis Pharma A/S ASND Stock Holding History

RhumbLine Advisers’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$11.9M Buy
52,145
+3,533
+7% +$895K 0.01% 968
2026
Q2 		$13M Buy
48,612
+46,887
+2,718% +$11M 0.01% 972
2026
Q1 		$395K Sell
1,725
-14
-0.8% -$3.14K ﹤0.01% 2751
2025
Q4 		$371K Buy
1,739
+604
+53% +$125K ﹤0.01% 2847
2025
Q3 		$226K Sell
1,135
-306
-21% -$57.1K ﹤0.01% 3164
2025
Q2 		$249K Buy
1,441
+55
+4% +$8.96K ﹤0.01% 3107
2025
Q1 		$216K Sell
1,386
-74
-5% -$10.6K ﹤0.01% 3069
2024
Q4 		$201K Sell
1,460
-108
-7% -$14.2K ﹤0.01% 3198
2024
Q3 		$234K Buy
1,568
+35
+2% +$4.73K ﹤0.01% 3157
2024
Q2 		$209K Buy
1,533
+143
+10% +$19.5K ﹤0.01% 3202
2024
Q1 		$210K Buy
1,390
+100
+8% +$14.3K ﹤0.01% 3151
2023
Q4 		$162K Buy
1,290
+22
+2% +$2.19K ﹤0.01% 3281
2023
Q3 		$119K Buy
1,268
+10
+0.8% +$936 ﹤0.01% 3401
2023
Q2 		$112K Buy
+1,258
New +$109K ﹤0.01% 3479

Other funds holding ASND

Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 42.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $54.9B AUM 27.38% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $229B AUM 33.35% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

RhumbLine Advisers's ASND Position: Q3 2026 in Review

RhumbLine Advisers increased its Ascendis Pharma A/S (ASND) stake by 7.3% in Q3 2026, buying an estimated $895K and bringing the position to 52,145 shares worth $11.9M. The position accounts for 0.01% of the portfolio, ranked #968.

RhumbLine Advisers first reported a position in ASND in Q2 2023 and has held it in 14 quarters since. The position peaked at $13M in Q2 2026. 252 funds tracked by Wall St. Rank hold ASND as of Q3 2026.

  • RhumbLine Advisers held 52,145 shares of Ascendis Pharma A/S worth $11.9M as of Q3 2026.
  • RhumbLine Advisers bought 3,533 Ascendis Pharma A/S shares in Q3 2026, an estimated $895K.
  • Ascendis Pharma A/S made up 0.01% of RhumbLine Advisers's portfolio in Q3 2026, its #968 holding.
  • RhumbLine Advisers first reported a position in Ascendis Pharma A/S in Q2 2023 and has held it in 14 quarters since.
  • RhumbLine Advisers's Ascendis Pharma A/S position peaked at $13M in Q2 2026.
  • 252 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q3 2026.

Based on RhumbLine Advisers's 13F filing for Q3 2026, filed 10 Nov 2026.